Skip to main content
Briefed

Topic

Avalyn Pharma

Everything Briefed has filed against Avalyn Pharma, most recent first.

1 story

Coverage1 shown

Top Stories
30 Apr 2026Novo-backed Avalyn raises $300m as biotech IPOs roar backAvalyn Pharma priced its IPO at the top of range and upsized to $300 million, making it one of 2026's largest biotech debuts. The inhaled lung disease specialist targets 100,000 US patients with re…

Often alongside

Artificial Intelligence6Capital Expenditure3Amazon2Data Centers2Federal Reserve2India2
Avalyn Pharma coverage from Briefed | Briefed Media